PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsObesity
MeSH D009765 - obesity
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D050177:Overweight
2 Companies
4 Drugs
$
Success rate
D009765: 
Obesity
47 Companies
19 Drugs
$
Success rate
D000067329:Metabolically benign obesity
0 Companies
0 Drugs
Success rate
D000079262:Maternal obesity
0 Companies
0 Drugs
Success rate
D009767:Morbid obesity
0 Companies
0 Drugs
Success rate
D010845:Obesity hypoventilation syndrome
0 Companies
0 Drugs
Success rate
D011218:Prader-willi syndrome
10 Companies
1 Drug
$
Success rate
D056128:Abdominal obesity
0 Companies
0 Drugs
Success rate
D063766:Pediatric obesity
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
3MDiethylpropion Tepanil  1982-01-01   
Diethylpropion Tepanil Ten-tab  1982-01-01   
Abbott BiotherapeuticsSibutramine Meridia  1997-11-22   
Able LaboratoriesPhentermine Phentermine  2001-08-30   
AllerganDiethylpropion Diethylpropion  1982-01-01   
PHENDIMETRAZINE Phendimetrazine  1982-01-01   
Phentermine Phentermine  1998-11-25   
AlpharmaHydrocodone, Phenylpropanolamine Codamine  2000-09-29   
Aurolife PharmaPhentermine Phentermine  2014-08-06   
Barr PharmaceuticalsPHENDIMETRAZINE Phendimetrazine  1982-01-01   
Phentermine Phentermine  2009-08-31   
Bausch Health CompaniesPHENDIMETRAZINE Bontril  1982-09-21   
PHENDIMETRAZINE Bontril Pdm  1982-01-01   
Chartwell PharmaceuticalsPHENDIMETRAZINE Cam-metrazine  1982-01-01   
Diethylpropion Diethylpropion  1983-08-25   
PHENDIMETRAZINE Phendimetrazine  1982-01-01   
Phentermine Phentermine  1982-01-01   
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
66%
84/127
Phase 2
69%
94/137
Phase 3
59%
64/108
Approved: 17Overall Success rate: 27%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Abbott Biotherapeutics
Sibutramine
Boehringer Ingelheim
Angiotensin ii,
Antithrombin iii
1
2
3
4
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use